Increasingly, commercial technologies are created, guided or accompanied by bioinformatics innovation, to the extent that those bioinformatics innovations may be as important as the biotech or electronic technologies they relate to.

Businesses that fail to adequately protect such bioinformatics innovation will miss out on significant value in their business.

We look at patent trends in bioinformatics along with some real life case studies in order to see how companies have successfully protected bioinformatics innovations in areas including computational neuroscience (including in silico brains), DNA Sequencing (where algorithms allow the detection of microbes down to the strain level) and remote healthcare monitoring (where wearable electronic devices and Internet of Things technologies are enabling increasingly sophisticated remote healthcare monitoring and intervention).


Dr Lauris Kemp and Dr Andrew McGettrick

You may also like

What happens when it goes wrong? Avoiding loss of patent rights in portfolio management

Thursday 11th March

In this session Vanessa will use case studies to help recognise risky practices in portfolio management and outline what can be done when something goes wrong.

Careful crafting and compliant claims; Advertising Standards Authority regulation in the health sector

23rd February

This session will examine the provisions of the Advertising Standards Authority codes which relate to the health sector. We will consider a number of recent decisions in this area and offer practical advice on how to ensure advertising for those operating in the healthcare sector is compliant with the ASA’s codes.

‘Strengthening your core’ – embedding a healthy risk management framework within the core of your business

Thursday 4th March

This session will look at a number of simple steps that can be taken to implement a healthy risk management framework within the core of a healthcare business – aimed at strengthening team culture and behavioural norms.